A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

Virginia Center for Reproductive Medicine128 enrolled

Overview

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Study Type

OBSERVATIONAL

Enrollment

128

Conditions

Infertility

Eligibility

Sex: FEMALEMin age: 21 YearsMax age: 42 Years

Medical Language ↔ Plain English

Inclusion Criteria: * women between 21-42 undergoing IVF Exclusion Criteria: * women \> 45, * women with one ovary, * donor egg, * surrogacy, * FET cycles, * uterine problems, * large fibroids

Locations (1)

Virginia Center for Reproductive Medicine

Reston, Virginia, United States

Outcomes

Primary Outcomes

Live birth rate

Time frame: 4 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.